Keyphrases
Acute Treatment
22%
Adrenocorticotropic Hormone
11%
Anti-inflammatory Drugs
11%
Biomarker Response
11%
C-reactive Protein Level
11%
Corticosterone Levels
11%
Dark Period
11%
Dark Phase
11%
Early Change
11%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Growth Hormone
11%
Hormone Levels
11%
Inflammatory Mediators
22%
Interferon-α (IFN-α)
11%
Interleukin-10
11%
Interleukin-1β
11%
Interleukin-6
11%
Intraperitoneal Injection
11%
Light Period
11%
Lipopolysaccharide
100%
Lipopolysaccharide-induced
100%
Locomotion
11%
Locomotor Activity
11%
Locomotor Deficits
11%
MAPK Inhibitors
100%
Neuroimmune Response
11%
Open Field Arena
11%
P38 Mitogen-activated Protein Kinase Inhibitor
11%
Peripheral Biomarkers
100%
Prolactin
11%
Psychomotor Retardation
100%
Sickness
11%
Sickness Behavior
22%
Specific Symptoms
11%
Sprague-Dawley Rats
11%
Stress Mediators
22%
Tumor Necrosis Factor-α
11%
Neuroscience
Adrenocorticotropic Hormone
9%
Anti-Inflammatory
9%
Blood Plasma
9%
Bovine Somatotropin
9%
C-Reactive Protein
9%
Corticosterone
9%
Cytokine
9%
Granulocyte Macrophage Colony-Stimulating Factor
9%
Growth Hormone
9%
Interferon
9%
Interleukin 1
9%
Interleukin 10
9%
Interleukin 6
9%
Intraperitoneal Injection
9%
Lipopolysaccharide
100%
Locomotion
9%
Locomotor Activity
9%
Necrosis
9%
P38 Mitogen-Activated Protein Kinases
100%
Prolactin
9%
Protein Kinase Inhibitor
9%
Psychomotor Retardation
100%
Sickness Behavior
18%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
9%
Biological Marker
100%
C Reactive Protein
9%
Corticosterone
9%
Corticotropin
9%
Cytokine
9%
Diseases
27%
Granulocyte Macrophage Colony Stimulating Factor
9%
Growth Hormone
9%
Inflammation
9%
Interferon
9%
Interleukin 1
9%
Interleukin 10
9%
Interleukin 6
9%
Intraperitoneal Injection
9%
Lipopolysaccharide
100%
Mitogen Activated Protein Kinase P38 Inhibitor
9%
Prolactin
9%
Psychomotor Retardation
100%
Sprague Dawley Rat
9%
Syndrome
9%
Tumor Necrosis Factor
9%